C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2004
11/18/2004	US20040229260 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases
11/18/2004	US20040229258 Methods of detecting neurological disorders
11/18/2004	US20040229257 Methods for the diagnosis and treatment of epilepsy
11/18/2004	US20040229249 Fibroblast growth factor polypeptide for identifying modulators for treatment of tumor neovascularization and diabetic retinopathy; wound healing agents; angiogenesis activator
11/18/2004	US20040229243 MarA family helix-turn-helix domains and their methods of use
11/18/2004	US20040229240 Identifying modulators of receptor ligand interaction; drug screening; yeast two-hybrid assay
11/18/2004	US20040229239 Comprises nucleotide sequences coding g-protein coupled receptors for identifying modulators of taste enhancement; food processing and drug design; screening tastants
11/18/2004	US20040229238 Comprises kinesin polypeptides for use as tools in identifying modulators for the treatment and prevention of cancer, neurological and vesicular transport disorders
11/18/2004	US20040229237 Inflammatory response protein for use in developing vaccines against allergic diseases; allergic response modulation; antiallergens
11/18/2004	US20040229235 Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis
11/18/2004	US20040229233 Human housekeeping genes and human-tissue specific genes
11/18/2004	US20040229232 Compositions and methods for the diagnosis and treatment of tumor
11/18/2004	US20040229229 Use of multiple recombination sites with unique specificity in recombinational cloning
11/18/2004	US20040229219 Comprises envelope peptide-glycoprotein fusion for use as preventative against respiratory viral infection
11/18/2004	US20040229214 Synthetic peptides immunoreactive with Hepatitis A virus antibodies
11/18/2004	US20040229212 Recombinant human mannan-binding lectin
11/18/2004	US20040229206 Pharmaceutical composition comprising carrier, mannose binding protein heterodimer and a lectin for use in treatment of blood an cell proliferative disorders; myeloablation therapies for treating cancer
11/18/2004	US20040228920 HoxD3, HoxA3, and HoxB3 compositions and methods for improved wound healing
11/18/2004	US20040228878 Recombinant infectious laryngotracheitis virus and uses thereof
11/18/2004	US20040228874 Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
11/18/2004	US20040228873 immunogens/vaccines against mycobactium tuberculosis
11/18/2004	US20040228870 Methods for promoting growth of bone, ligament, and cartilage
11/18/2004	US20040228867 Method for screening transcriptional coregulatory proteins of transcription factors, and androgen receptor transcriptional coregulatory proteins as targets for androgen receptor-dependent diseases
11/18/2004	US20040228866 Suppressor genes
11/18/2004	US20040228865 Prevention and treatment of amyloidogenic disease
11/18/2004	US20040228864 polypeptides whose presence is associated with inflammatory diseases (inflammation associated antigens) and/or cancer
11/18/2004	US20040228855 Method for treating symptoms of diabetes
11/18/2004	US20040228851 identifying an agent that reduces the lipid binding activity of an apoE stable folding intermediate, the method comprising by contacting an apoE stable folding intermediate in a solution with a test agent and determining the effect
11/18/2004	US20040228843 Preparing chimeric expression vector for use as gene transfer tool in heterologous gene expression; tissue engineering
11/18/2004	US20040228842 Compositions and methods for cytomegalovirus treatment
11/18/2004	US20040228841 Replication-competent herpes simplex virus mediates destruction of neoplastic cells
11/18/2004	US20040228840 Vector for integration of heterologous sequences into poxviral genomes
11/18/2004	US20040228838 Viral interleukin-6
11/18/2004	US20040228836 cancer therapeutic agent comprising a cancer targeting molecule linked to a liver-expressed chemokine (LEC)
11/18/2004	US20040228798 A conjugated drug contains virus-like particle is joined to the antigen by a biotin molecule; bioassay; inhibiting HIV infection, viral infection
11/18/2004	DE19882755B4 Ein Fusionsprotein des hEGF und des humanen Angiogenins und ein Verfahren zu dessen Herstellung A fusion protein of hEGF and human angiogenin, and a process for its preparation
11/18/2004	DE10315834A1 Humane Nukleinsäuresequenzen aus Pankreaskarzinomen Nucleic acid sequences from human pancreatic cancer
11/18/2004	DE10297331T5 Behandlung und Diagnose von Insulin-resistenten Zuständen Treatment and diagnosis of insulin-resistant conditions
11/18/2004	DE10261650A1 Verwendung des multifunktionellen Transkriptionsfaktors Yin-Yang-1 und Varianten davon zur Behandlung von Erkrankungen, insbesondere von Typ-1 Diabetes Use of the multifunctional transcription factor Yin Yang 1 and variants thereof for the treatment of diseases, especially of type 1 diabetes
11/18/2004	CA2766627A1 Optimized fc variants and methods for their generation
11/18/2004	CA2525493A1 Human blood proteins expressed in monocot seeds
11/18/2004	CA2524799A1 Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production
11/18/2004	CA2524623A1 Immunogenic human tnf alpha analogues with reduced cytotoxicity and methods of their preparation
11/18/2004	CA2524609A1 Peptides and mixtures thereof for use in the detection of severe acute respiratory syndrome-associated coronavirus (sars)
11/18/2004	CA2524528A1 Truncated forms of human dbf4, complexes with their interacting partners and methods for identification of inhibitors thereof
11/18/2004	CA2524277A1 Arg-pro-pro-gly-phe analogs as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
11/18/2004	CA2524172A1 Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses
11/18/2004	CA2523932A1 Selective r-cadherin antagonists and methods
11/18/2004	CA2523765A1 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
11/18/2004	CA2523720A1 Synthetic gene encoding human carcinoembryonic antigen and uses thereof
11/18/2004	CA2523414A1 Peptides having an ace inhibiting effect
11/18/2004	CA2523410A1 Hydrolysed casein product comprising tripeptides ipp and/or vpp
11/18/2004	CA2523408A1 Peptides for use in treating obesity
11/18/2004	CA2522986A1 Streptococcus agalactiae antigens i + ii
11/18/2004	CA2522574A1 Hepatitis c virus ns5b polymerase inhibitor binding pocket
11/18/2004	CA2522345A1 Glycopegylation methods and proteins/peptides produced by the methods
11/18/2004	CA2519680A1 Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes
11/18/2004	CA2500523A1 Vp2-modified raav vector compositions and uses therefor
11/17/2004	WO2004107200A1 System and method for controlling user interface properties with data
11/17/2004	EP1477806A1 Method of determining ligand
11/17/2004	EP1477562A1 Transcriptional factor, transcriptional factor gene, recombinant vector containing transcriptional factor gene, koji-mold transformed by the vector and method of using koji-mold
11/17/2004	EP1477560A1 Alga-origin promoter, intron and terminator
11/17/2004	EP1477559A1 Novel polypeptide
11/17/2004	EP1477497A1 Humanized immunoglobulins and their production and use
11/17/2004	EP1477496A1 Peg-conjugated pth or peg-conjugated pth derivate
11/17/2004	EP1477495A1 Antigenic fragments of the gp21 envelope protein of human T-Lymphotropic virus HTLV
11/17/2004	EP1477494A1 Subunit respiratory syncytial virus vaccine preparation
11/17/2004	EP1477493A1 Isotope coded affinity tags
11/17/2004	EP1477185A2 Pneumococcal genes, portions thereof, expression products therefrom and uses of such genes, portions and products
11/17/2004	EP1477183A1 Botulinum toxins for modulating cholinergic controlled secretions
11/17/2004	EP1476750A1 Method for producing a nucleosome preparation and use thereof in in vitro diagnosis of disseminated lupus erythematosus (dle)
11/17/2004	EP1476746A2 Method for discovering pharmacologically active substances
11/17/2004	EP1476582A1 Nucleotide sequence coding for a tolc containing a heterologous amino acid sequence
11/17/2004	EP1476581A2 Recombinant bovine immunodeficiency virus based gene transfer system
11/17/2004	EP1476554A1 Novel compound for inhibiting serine proteases and for inhibiting viral infections or viral propagation: rld 8564
11/17/2004	EP1476553A2 Gene for peripheral arterial occlusive disease
11/17/2004	EP1476551A2 Method for the identification of tissue-specific regulatory sequences
11/17/2004	EP1476543A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
11/17/2004	EP1476541A2 Novel cytokine zcytor17 ligand
11/17/2004	EP1476471A1 Nutraceuticals for the treatment, protection and restoration of connective tissues
11/17/2004	EP1476466A1 Management of mucosal viscosity by tff monomer peptides
11/17/2004	EP1476465A1 Method for producing interferon
11/17/2004	EP1476463A1 Mhc class i peptide epitopes from the human 5t4 tumor-associated antigen
11/17/2004	EP1476461A2 Immune-modulating peptide made of s. aureus enterotoxin b
11/17/2004	EP1476460A2 A nucleic acid encoding a g-protein-coupled receptor; and uses thereof
11/17/2004	EP1476456A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/17/2004	EP1476204A1 Immobilized bioactive hydrogel matrices as surface coatings
11/17/2004	EP1476202A1 Cross-linked bioactive hydrogel matrices
11/17/2004	EP1476197A2 Synthesis of lipopolysaccharide-protein conjugate vaccines via the lipid a region following removal of the glycosidic phosphate residue
11/17/2004	EP1476182A1 Immunogenic formulations of variable peptidic epitopes and process for preparation thereof
11/17/2004	EP1476180A2 Interleukin-2 mutants with reduced toxicity
11/17/2004	EP1476178A2 Formulation strategies in stabilizing peptides in organic solvents and in dried states
11/17/2004	EP1476177A2 Peptide constructs for treating disease
11/17/2004	EP1476067A2 Novel compositions and methods for cancer
11/17/2004	EP1427439A4 Gamma three protease
11/17/2004	EP1363658B1 Beta-endorphin / crf - gene therapy for combatting pain locally
11/17/2004	EP1337543A4 Streptavidin-binding peptides and uses thereof
11/17/2004	EP1180168B1 MOLECULAR CHARACTERISATION OF CHROMOSOME TRANSLOCATION t(11;18)(q21;q21) AND ITS CORRELATION TO CARCINOGENESIS
11/17/2004	EP1157039B1 Collagen peptides modified by grafting mercapto functions, method for the production thereof and uses thereof as biomaterials
11/17/2004	EP1137667B1 Analogues of glp-1

1 ... 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 ... 2916